发明名称 |
DETERMINING SENSITIVITY OF CELLS TO B-RAF INHIBITOR TREATMENT BY DETECTING KRAS MUTATION AND RTK EXPRESSION LEVELS |
摘要 |
The present invention relates to prognostic methods for identifying tumors that are not susceptible to B-Raf inhibitor treatment by detecting mutations in a K-ras gene or protein or by detecting overexpression of RTKs and/or their ligands. Kits are also disclosed for carrying out the methods. |
申请公布号 |
US2015164895(A1) |
申请公布日期 |
2015.06.18 |
申请号 |
US201414284027 |
申请日期 |
2014.05.21 |
申请人 |
GENENTECH, INC. |
发明人 |
Hatzivassiliou Georgia;Malek Shiva |
分类号 |
A61K31/517;G01N33/574 |
主分类号 |
A61K31/517 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method of identifying a patient nonresponsive to treatment with a B-Raf inhibitor, comprising determining the presence or absence of a K-ras mutation, whereby the presence of a K-ras mutation indicates a patient will not respond to said B-Raf inhibitor treatment. |
地址 |
SOUTH SAN FRANCSICO CA US |